Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress

Osteoporosis (OP), a systemic and chronic bone disease, is distinguished by low bone mass and destruction of bone microarchitecture. Ginsenoside Compound-K (CK), one of the metabolites of ginsenoside Rb1, has anti-aging, anti-inflammatory, anti-cancer, and hypolipidemic activities. We have demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Lingli, Gao, Zhao, Wu, Siluo, Chen, Chen, Liu, Yamei, Wang, Min, Zhang, Yage, Li, Ling, Zou, Hong, Zhao, Guoping, Qin, Shengnan, Xu, Liangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632357/
https://www.ncbi.nlm.nih.gov/pubmed/37940733
http://dx.doi.org/10.1007/s13659-023-00405-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632357/
https://www.ncbi.nlm.nih.gov/pubmed/37940733
http://dx.doi.org/10.1007/s13659-023-00405-z

Ejemplares similares